Cell compositions derived from dedifferentiated reprogrammed cells
US9982235B2 · kind B2 · utility
6Cited by
48References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 7, 2015 |
| Grant date | May 29, 2018 |
| Priority date | — |
| Expiry date | Jul 7, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2506/45
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are cell culture compositions, for example, pancreatic cell culture compositions, derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells, and methods for producing and using such cell culture compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.